Please wait while we load the requested 10-Q report or click the link below:
Sales of $20.7 Billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic
EPS of $2.17 increased 56.1%; adjusted EPS of $2.30 increased 9.5%*
Dividend increase of 6.3% announced
Long term fundamentals remain intact; 2020 Guidance lowered to reflect COVID-19 impact and related investments
The following information was filed by Johnson Johnson (JNJ) on Tuesday, April 14, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Johnson Johnson's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Johnson Johnson.